Abstract:Since synthetic analogs of 1,4-anthraquinone (AQ code number), such as AQ8, AQ9 and AQ10, can trigger cytochrome c release without caspase activation and retain their ability to induce apoptosis in multidrug-resistant (MDR) tumor cells, fluorescent probes of transmembrane potential have been used to determine whether these anti-tumor compounds might directly target mitochondria in cell and cell-free systems to cause the collapse of mitochondrial membrane potential (down arrow Delta Psi m) that is linked to permeability transition pore (PTP) opening. Using JC-1 dye, the abilities of various AQ analogs to induce the down arrow Delta Psi m in wild-type and MDR HL-60 cells are rapid (within 2.5-10 min), irreversible after drug removal, concentration dependent in the 0.256-10 mu mol/l range and generally related to their anti-tumor activities in vitro. The down arrow Delta Psi m caused by AQ9 and AQ10, which are more potent than mitoxantrone, staurosporine and the reference depolarizing agent carbonyl cyanide m-chlorophenylhydrazone (CCCP) in HL-60 cells, are not prevented by caspase-2 or -8 inhibitors, suggesting that activations of these apical caspases upstream of mitochondria are not involved in this process. Antitumor AQ analogs (0.256-10 mu mol/l) also mimic the abilities of the known depolarizing agents CCCP, alamethicin, gramicidin A and 100 mu mol/l CaCl2 to directly induce within 15 min the down arrow Delta Psi m in isolated mitochondria prepared from mouse liver and loaded with rhodamine 123 dye. The fact that 20 mu mol/l Ca2+, which is insufficient to trigger depolarization on its own, is required to reveal the depolarizing effect of AQ9 in isolated mitochondria suggests that anti-tumor AQ analogs might interact with the PTP to alter its conformation and increase its Ca2+ sensitivity. Indeed, such Ca2+-dependent down arrow Delta Psi m of isolated mitochondria treated with 1.6 mu mol/l AQ9 or 100 mu mol/l Ca2+ are blocked by ruthenium red. Daunorubicin (DAU) is unable to mimic the rapid down arrow Delta Psi m caused by anti-tumor AQ analogs within 2.5-40 min of treatment in HL-60 cells or isolated mitochondria. Moreover, the down arrow Delta Psi m caused by 1.6 mu mol/l AQ9 or 100 mu mol/l Ca2+ in isolated mitochondria are similarly blocked by cyclosporin A (CsA), bongkrekic acid and decylubiquinone, which prevent PTP opening, suggesting that, in contrast to DAU, anti-tumor AQ analogs that directly target mitochondria to trigger the Ca2+-dependent and CsA-sensitive down arrow Delta Psi m, might induce PTP opening and the mitochondrial pathway of apoptosis even in the absence of nuclear signals.

p38 mitogen-activated protein kinase is required for the antitumor activity of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.

Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase

DMXAA Causes Tumor Site-Specific Vascular Disruption in Murine Non-Small Cell Lung Cancer, and like the Endogenous Non-Canonical Cyclic Dinucleotide STING Agonist, 2′3′-cGAMP, Induces M2 Macrophage Repolarization

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA

A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis

p38 in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1

Figure S3 from P38γ MAPK is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis

p38α in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1

p38 MAPK signaling mediates mitochondrial apoptosis in cancer cells induced by oleanolic acid.

Activation of p38 mitogen-activated protein kinase induced by tumor necrosis factor-α in human pulmonary microvascular endothelial cells

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

Nocodazole increases the ERK activity to enhance MKP-1 expression which inhibits p38 activation induced by TNF-α

p38 MAPK Contributes to the Growth Inhibition of Leukemic Tumor Cells Mediated by Human Umbilical Cord Mesenchymal Stem Cells

Functions of P38 Mitogen-Activated Protein Kinase Alpha and Beta in Human Pancreatic Cancer Cells

P38α Mitogen-Activated Protein Kinase is a Druggable Target in Pancreatic Adenocarcinoma

Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial

Reducing White Adipose Tissue Browning Using p38α MAPK Inhibitors Ameliorates Cancer-Associated Cachexia as Assessed by Magnetic Resonance Imaging

P38 Mitogen-activated Protein Kinase Mediates Hypoxia-Induced Vascular Endothelial Growth Factor Release in Human Endothelial Cells.

P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma

P38 MAP Kinase Interacts with and Stabilizes Pancreatic and Duodenal Homeobox-1

Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones.